A bio-inspired glucose controller based on pancreatic β-cell physiology

Journal of Diabetes Science and Technology

Volumn 6, Issue 3, 2012, Pages 606-616

  Herrero, Pau ^a   Georgiou, Pantelis ^a   Oliver, Nick ^a,b   Johnston, Desmond G ^a,b   Toumazou, Christofer ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

Artificial pancreas; Bio inspired technology; Closed loop; Diabetes management; Glycemic control

Indexed keywords

GLUCOSE; INSULIN; ANTIDIABETIC AGENT;

ADOLESCENT; ADULT; ARTICLE; BIO INSPIRED GLUCOSE CONTROLLER; BLOOD GLUCOSE MONITORING; CELL FUNCTION; CLINICAL ARTICLE; COMPUTER SIMULATION; DISEASE SIMULATION; FEEDBACK SYSTEM; GLUCOSE BLOOD LEVEL; GLUCOSE SENSOR; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSTRUMENT VALIDATION; INSULIN DEPENDENT DIABETES MELLITUS; MATHEMATICAL MODEL; PANCREAS ISLET BETA CELL; POSTPRANDIAL STATE; VALIDITY; VIRTUAL REALITY; ALGORITHM; AMBULATORY MONITORING; ARTIFICIAL PANCREAS; BIOLOGICAL MODEL; BLOOD; BLOOD ANALYSIS; CHEMICALLY INDUCED DISORDER; DRUG ADMINISTRATION; DRUG EFFECT; EQUIPMENT; EQUIPMENT DESIGN; GENETIC PROCEDURES; INFUSION; INSULIN INFUSION; METABOLISM; PATHOPHYSIOLOGY; PREDICTIVE VALUE; REPRODUCIBILITY; TREATMENT OUTCOME; VALIDATION STUDY;

ADOLESCENT; ADULT; ALGORITHMS; BIOSENSING TECHNIQUES; BLOOD CHEMICAL ANALYSIS; BLOOD GLUCOSE; COMPUTER SIMULATION; DIABETES MELLITUS, TYPE 1; DRUG ADMINISTRATION SCHEDULE; EQUIPMENT DESIGN; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INFUSIONS, PARENTERAL; INSULIN; INSULIN INFUSION SYSTEMS; INSULIN-SECRETING CELLS; MODELS, BIOLOGICAL; MONITORING, AMBULATORY; PANCREAS, ARTIFICIAL; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84875462385     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681200600316     Document Type: Article

References (38)

1. Hovorka R. Continuous glucose monitoring and closed-loop systems. Diab Med. 2006;23(1):1-12.
2. Kovatchev B, Anderson S, Heinemann L, Clarke W. Comparison of the numerical and clinical accuracy of four continuous glucose monitors. Diabetes Care. 2008;31(6):1160-4.
3. Bequette BW. A critical assessment of algorithms and challenges in the development of a closed-loop artificial pancreas. Diabetes Technol Ther. 2005;7(1):28-47. (Pubitemid 40354574)
4. Rowe R. Insulin pump therapy. Diabet Medicine. 2001;18(Suppl 4):4-5. (Pubitemid 34178642)
5. Steil GM, Rebrin K, Darwin C, Hariri F, Saad MF. Feasibility of automating insulin delivery for the treatment of type 1 diabetes. Diabetes. 2006;55(12):3344-50. (Pubitemid 44923591)
6. Hovorka R, Canonico V, Chassin LJ, Haueter U, Massi-Benedetti M, Orsini Federici M, Pieber TR, Schaller HC, Schaupp L, Vering T, Wilinska ME. Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes. Physiol Mea. 2004;25(4):905-20. (Pubitemid 39121173)
7. El-Khatib FH, Russell SJ, Nathan DM, Sutherlin RG, Damiano ER. A bihormonal closed-loop artificial pancreas for type 1 diabetes. Sci Transl Med. 2010;2(27):27ra27.
8. Atlas E, Nimri R, Miller S, Grunberg EA, Phillip M. MD-logic artificial pancreas system: a pilot study in adults with type 1 diabetes. Diabetes Care. 2010;33(5):1072-6.
9. Campos-Delgado DU, Hernández-Ordoñez M, Femat R, Gordillo-Moscoso A. Fuzzy-based controller for glucose regulation in type-1 diabetic patients by subcutaneous route. IEEE Trans Biomed Eng. 2006;53(11):2201-10. (Pubitemid 44629858)
10. Mead C. Analog VLSI and neural systems. Reading (MA): Addison-Wesley; 1989.
11. Georgiou J, Toumazou C. A 126-μW cochlear chip for a totally implantable system. IEEE J Solid State Circuit. 2005;40(2):430-43. (Pubitemid 40206714)
12. Degenaar P, Grossman N, Memon MA, Burrone J, Dawson M, Drakakis E, Neil M, Nikolic K. Optobionic vision-a new genetically enhanced light on retinal prosthesis. J Neural Eng. 2009;6(3):035007.
13. Constandinou TG, Georgiou J, Toumazou C. A neural implant ASIC for the restoration of balance in individuals with vestibular dysfunction. ISCAS 2009: IEEE International Symposium on Circuits and Systems; 2009 May 24-27; Taipei, Taiwan. p. 641-644.
14. Caumo A, Luzi L. First-phase insulin secretion: does it exist in real life? Considerations on shape and function. Am J Physiol Endocrinol Metab. 2004;287(3):E371-85. (Pubitemid 39095870)
15. Steil GM, Panteleon AE, Rebrin K. Closed-loop insulin delivery-the path to physiological glucose control. Adv Drug Deliv Rev. 2004;56(2)125-44. (Pubitemid 38114927)
16. Keenan DB, Mastrototaro JJ, Voskanyan G, Steil GM. Delays in minimally invasive continuous glucose monitoring devices: a review of current technology. J Diabetes Sci Technol. 2009;3(5):1207-14.
17. Heinemann L. Variability of insulin absorption and insulin action. Diabetes Technol Ther. 2002;4(5):673-82. (Pubitemid 35283332)
18. Steil GM, Rebrin K, Janowski R, Darwin C, Saad MF. Modeling beta-cell insulin secretion-implications for closed-loop glucose homeostasis. Diabetes Technol Ther. 2003;5(6):953-64. (Pubitemid 38009933)
19. Breda E, Tofolo G, Polonsky KS, Cobelli C. Insulin release in impaired glucose tolerance: oral minimal model predicts normal sensitivity to glucose but defective response times. Diabetes. 2002;51(Suppl 1):S227-33. (Pubitemid 34761520)
20. Oliver N, Georgiou P, Johnston D, Toumazou C. A benchtop closedloop system controlled by a bio-inspired silicon implementation of the pancreatic beta cell. J Diabetes Sci Technol. 2009;3(6):1419-24.
21. Pedersen MG, Bertram R, Sherman A. Intra- and inter-islet synchronization of metabolically driven insulin secretion. Biophys J. 2005;89(1):107-19. (Pubitemid 41098268)
22. .Bertuzzi A, Salinari S, Mingrone G. Insulin granule traficking in β-cells: mathematical model of glucose-induced insulin secretion. Am J Physiol Endocrinol Metab. 2007;293(1):E396-409. (Pubitemid 47105955)
23. Chen Y, Wang S, Sherman A. Identifying the targets of the amplifying pathway for insulin secretion in pancreatic β-cells by kinetic modeling of granule exocytosis. Biophysical J. 2008;95(5):2226-41.
24. Pedersen MG, Tofolo GM, Cobelli C. Cellular modeling: insight into oral minimal models of insulin secretion. Am J Physiol Endocrinol Metab. 2010;298(3):E597-601.
25. Kovatchev BP, Breton M, Dalla Man C, Cobelli C. In silico preclinical trials: A proof of concept in closed-loop control of type 1 diabetes. J Diabetes Sci Technol. 2009;3(1):44-55.
26. Hovorka R, Chassin L, Luzio SD, Playle R, Owens DR. Pancreatic β-cell responsiveness during meal tolerance test: model assessment in normal subjects and subjects with newly diagnosed noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1998;83(3):744-50. (Pubitemid 28496439)
27. Tofolo G, Breda E, Cavaghan MK, Ehrmann DA, Polonsky KS, Cobelli C. Quantitative indexes of β-cell function during graded up&down glucose infusion from C-peptide minimal models. Am J Physiol Endocrinol Metab. 2001;280(1):E2-10.
28. Cretti A, Lehtovirta M, Bonora E, Brunato B, Zenti MG, Tosi F, Caputo M, Caruso B, Groop LC, Muggeo M, Bonadonna RC. Assessment of β-cell function during the oral glucose tolerance test by a minimal model of insulin secretion. Eur J Clin Invest. 2001;31(5):405-16. (Pubitemid 32476960)
29. Mari A, Schmitz O, Gastaldelli A, Oestergaard T, Nyholm B, Ferrannini E. Meal and oral glucose tests for assessment of β-cell function: modeling analysis in normal subjects. Am J Physiol Endocrinol Metab. 2002;283(6):E1159- 66. (Pubitemid 35340621)
30. .Pedersen MG, Corradin A, Tofolo GM, Cobelli C. A subcellular model of glucose-stimulated pancreatic insulin secretion. Philos Transact A Math Phys Eng Sci. 2008;366(1880):3525-43.
31. Grodsky GM. A threshold distribution hypothesis for packet storage of insulin and its mathematical modeling. J Clin Invest. 1972;51(8):2047-59.
32. Dassau E, Bequette BW, Buckingham BA, Doyle FJ 3rd. Detection of a meal using continuous glucose monitoring: implications for an artificial β-cell. Diabetes Care. 2008;31(2):295-300. (Pubitemid 351213339)
33. Dassau E, Cameron F, Lee H, Bequette BW, Zisser H, Jovanovic L, Chase HP, Wilson DM, Buckingham BA, Doyle FJ 3rd. Realtime hypoglycemia prediction suite using continuous glucose monitoring: a safety net for the artificial pancreas. Diabetes Care. 2010;33(6):1249-54.
34. .Weinzimer SA, Steil GM, Swan KL, Dziura J, Kurtz N, Tamborlane WV. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care. 2008;31(5):934-9.
35. Steil G, Rebrin K, Mastrototaro JJ. Metabolic modelling and the closed-loop insulin delivery problem. Diabetes Res Clin Pract. 2006;74(Suppl 2):S183-6. (Pubitemid 44917763)
36. Lee H, Buckingham BA, Wilson DM, Bequette BW. A closed loop artificial pancreas using model predictive control and a sliding meal size estimator. J Diabetes Sci Technol. 2009;3(5):1082-90.
37. Clarke W, Kovatchev B. Statistical tools to analyze continuous glucose monitor data. Diabetes Technol Ther. 2009;11(Suppl 1):S45-54.
38. Magni L, Raimondo DM, Dalla Man C, Breton M, Patek S, Nicolao GD, Cobelli C, Kovatchev BP. Evaluating the eficacy of closed-loop glucose regulation via control-variability grid analysis. J Diabetes Sci Technol. 2008;2(4):630-5.